Med Life Past Earnings Performance
Past criteria checks 2/6
Med Life's earnings have been declining at an average annual rate of -9.7%, while the Healthcare industry saw earnings growing at 11.5% annually. Revenues have been growing at an average rate of 21.2% per year. Med Life's return on equity is 1.6%, and it has net margins of 0.7%.
Key information
-9.7%
Earnings growth rate
-11.9%
EPS growth rate
| Healthcare Industry Growth | 13.4% |
| Revenue growth rate | 21.2% |
| Return on equity | 1.6% |
| Net Margin | 0.7% |
| Next Earnings Update | 15 Nov 2024 |
Recent past performance updates
Recent updates
Is Med Life S.A. (BVB:M) Trading At A 41% Discount?
Aug 06
The Market Lifts Med Life S.A. (BVB:M) Shares 25% But It Can Do More
Jun 08Is Med Life (BVB:M) A Risky Investment?
Apr 05Returns On Capital Signal Tricky Times Ahead For Med Life (BVB:M)
Jul 05Is Med Life (BVB:M) A Risky Investment?
Jan 06Med Life (BVB:M) Hasn't Managed To Accelerate Its Returns
Dec 06We Think Med Life (BVB:M) Is Taking Some Risk With Its Debt
Sep 27Returns Are Gaining Momentum At Med Life (BVB:M)
May 05Is There An Opportunity With Med Life S.A.'s (BVB:M) 49% Undervaluation?
Mar 01Med Life (BVB:M) Shareholders Will Want The ROCE Trajectory To Continue
Jan 22Does Med Life (BVB:M) Have A Healthy Balance Sheet?
Aug 31Med Life's (BVB:M) Returns On Capital Are Heading Higher
Jun 10Here's Why We Think Med Life (BVB:M) Is Well Worth Watching
May 26Is Now An Opportune Moment To Examine Med Life S.A. (BVB:M)?
May 12Is There An Opportunity With Med Life S.A.'s (BVB:M) 24% Undervaluation?
Apr 12Update: Med Life (BVB:M) Stock Gained 98% In The Last Year
Mar 16Should We Be Excited About The Trends Of Returns At Med Life (BVB:M)?
Mar 04Should You Be Impressed By Med Life S.A.'s (BVB:M) ROE?
Feb 20
Med Life (BVB:M) Seems To Use Debt Quite Sensibly
Feb 07Is It Too Late To Consider Buying Med Life S.A. (BVB:M)?
Jan 25Do Med Life's (BVB:M) Earnings Warrant Your Attention?
Jan 08Is Med Life S.A. (BVB:M) Trading At A 22% Discount?
Dec 23Did You Miss Med Life's (BVB:M) 49% Share Price Gain?
Dec 08The Trends At Med Life (BVB:M) That You Should Know About
Nov 24Revenue & Expenses Breakdown
How Med Life makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 2,461 | 18 | 786 | 0 |
| 31 Mar 24 | 2,337 | 11 | 740 | 0 |
| 31 Dec 23 | 2,222 | 4 | 697 | 0 |
| 30 Sep 23 | 2,116 | -11 | 648 | 0 |
| 30 Jun 23 | 2,020 | -3 | 609 | 0 |
| 31 Mar 23 | 1,921 | 12 | 568 | 0 |
| 31 Dec 22 | 1,810 | 32 | 524 | 0 |
| 30 Sep 22 | 1,725 | 64 | 491 | 0 |
| 30 Jun 22 | 1,623 | 80 | 465 | 0 |
| 31 Mar 22 | 1,520 | 98 | 437 | 0 |
| 01 Jan 22 | 1,438 | 103 | 415 | 0 |
| 30 Sep 21 | 1,359 | 107 | 400 | 0 |
| 30 Jun 21 | 1,295 | 112 | 379 | 0 |
| 31 Mar 21 | 1,160 | 83 | 339 | 0 |
| 01 Jan 21 | 1,087 | 57 | 323 | 0 |
| 30 Sep 20 | 1,033 | 36 | 295 | 0 |
| 30 Jun 20 | 974 | 16 | 289 | 0 |
| 31 Mar 20 | 1,007 | 18 | 307 | 0 |
| 31 Dec 19 | 975 | 14 | 300 | 0 |
| 30 Sep 19 | 939 | 20 | 311 | 0 |
| 30 Jun 19 | 902 | 16 | 304 | 0 |
| 31 Mar 19 | 861 | 11 | 365 | 0 |
| 01 Jan 19 | 804 | 13 | 290 | 0 |
| 30 Sep 18 | 745 | 8 | 284 | 0 |
| 30 Jun 18 | 699 | 5 | 277 | 0 |
| 31 Mar 18 | 657 | 5 | 265 | 0 |
| 01 Jan 18 | 628 | 4 | 265 | 0 |
| 30 Sep 17 | 610 | 3 | 261 | 0 |
| 30 Jun 17 | 577 | -2 | 256 | 0 |
| 31 Mar 17 | 539 | -6 | 227 | 0 |
| 01 Jan 17 | 508 | -5 | 227 | 0 |
| 30 Sep 16 | 469 | -1 | 214 | 0 |
| 31 Dec 15 | 396 | 9 | 165 | 0 |
| 31 Dec 14 | 337 | 7 | 143 | 0 |
| 31 Dec 13 | 306 | -4 | 128 | 0 |
Quality Earnings: M has high quality earnings.
Growing Profit Margin: M became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: M's earnings have declined by 9.7% per year over the past 5 years.
Accelerating Growth: M has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: M has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (15.5%).
Return on Equity
High ROE: M's Return on Equity (1.6%) is considered low.